vs
Dayforce（DAY）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是Dayforce的1.0倍（$493.8M vs $481.6M），Pediatrix Medical Group, Inc.净利率更高（6.8% vs -40.9%，领先47.7%），Dayforce同比增速更快（9.5% vs -1.7%），过去两年Dayforce的营收复合增速更高（9.8% vs -0.1%）
Dayforce前身为知名人力资源服务商Ceridian，是一家总部位于美国的人力资源软件及服务企业，面向各行业不同规模的客户提供覆盖薪酬核算、人员管理、考勤等多场景的HR SaaS产品及配套专业服务，助力企业提升人力资源运营效率。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
DAY vs MD — 直观对比
营收规模更大
MD
是对方的1.0倍
$481.6M
营收增速更快
DAY
高出11.2%
-1.7%
净利率更高
MD
高出47.7%
-40.9%
两年增速更快
DAY
近两年复合增速
-0.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $481.6M | $493.8M |
| 净利润 | $-196.8M | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | 6.3% | 9.9% |
| 净利率 | -40.9% | 6.8% |
| 营收同比 | 9.5% | -1.7% |
| 净利润同比 | -9940.0% | 10.5% |
| 每股收益（稀释后） | $-1.23 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DAYMD
| Q4 25 | — | $493.8M | ||
| Q3 25 | $481.6M | $492.9M | ||
| Q2 25 | $464.7M | $468.8M | ||
| Q1 25 | $481.8M | $458.4M | ||
| Q4 24 | $465.2M | $502.4M | ||
| Q3 24 | $440.0M | $511.2M | ||
| Q2 24 | $423.3M | $504.3M | ||
| Q1 24 | $431.5M | $495.1M |
净利润DAYMD
| Q4 25 | — | $33.7M | ||
| Q3 25 | $-196.8M | $71.7M | ||
| Q2 25 | $21.3M | $39.3M | ||
| Q1 25 | $14.9M | $20.7M | ||
| Q4 24 | $10.8M | $30.5M | ||
| Q3 24 | $2.0M | $19.4M | ||
| Q2 24 | $-1.8M | $-153.0M | ||
| Q1 24 | $7.1M | $4.0M |
毛利率DAYMD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 47.0% | — | ||
| Q3 24 | 45.8% | — | ||
| Q2 24 | 44.1% | — | ||
| Q1 24 | 47.6% | — |
营业利润率DAYMD
| Q4 25 | — | 9.9% | ||
| Q3 25 | 6.3% | 13.8% | ||
| Q2 25 | 9.1% | 12.8% | ||
| Q1 25 | 6.4% | 7.0% | ||
| Q4 24 | 6.1% | 7.8% | ||
| Q3 24 | 4.7% | 6.6% | ||
| Q2 24 | 3.3% | -31.3% | ||
| Q1 24 | 9.4% | 3.2% |
净利率DAYMD
| Q4 25 | — | 6.8% | ||
| Q3 25 | -40.9% | 14.5% | ||
| Q2 25 | 4.6% | 8.4% | ||
| Q1 25 | 3.1% | 4.5% | ||
| Q4 24 | 2.3% | 6.1% | ||
| Q3 24 | 0.5% | 3.8% | ||
| Q2 24 | -0.4% | -30.3% | ||
| Q1 24 | 1.6% | 0.8% |
每股收益（稀释后）DAYMD
| Q4 25 | — | $0.40 | ||
| Q3 25 | $-1.23 | $0.84 | ||
| Q2 25 | $0.13 | $0.46 | ||
| Q1 25 | $0.09 | $0.24 | ||
| Q4 24 | $0.07 | $0.37 | ||
| Q3 24 | $0.01 | $0.23 | ||
| Q2 24 | $-0.01 | $-1.84 | ||
| Q1 24 | $0.04 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $627.6M | $375.2M |
| 总债务越低越好 | $631.1M | $570.5M |
| 股东权益账面价值 | $2.7B | $865.9M |
| 总资产 | $8.7B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.23× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资DAYMD
| Q4 25 | — | $375.2M | ||
| Q3 25 | $627.6M | $340.1M | ||
| Q2 25 | $625.2M | $224.7M | ||
| Q1 25 | $557.3M | $99.0M | ||
| Q4 24 | $579.7M | $229.9M | ||
| Q3 24 | $494.1M | $103.8M | ||
| Q2 24 | $465.4M | $19.4M | ||
| Q1 24 | $392.5M | $8.0M |
总债务DAYMD
| Q4 25 | — | $570.5M | ||
| Q3 25 | $631.1M | $577.2M | ||
| Q2 25 | $631.8M | $583.9M | ||
| Q1 25 | $632.4M | $590.5M | ||
| Q4 24 | $1.2B | $597.1M | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
股东权益DAYMD
| Q4 25 | — | $865.9M | ||
| Q3 25 | $2.7B | $890.7M | ||
| Q2 25 | $2.7B | $833.8M | ||
| Q1 25 | $2.6B | $789.2M | ||
| Q4 24 | $2.5B | $764.9M | ||
| Q3 24 | $2.6B | $732.5M | ||
| Q2 24 | $2.5B | $706.5M | ||
| Q1 24 | $2.4B | $856.2M |
总资产DAYMD
| Q4 25 | — | $2.2B | ||
| Q3 25 | $8.7B | $2.2B | ||
| Q2 25 | $8.5B | $2.1B | ||
| Q1 25 | $9.5B | $2.0B | ||
| Q4 24 | $9.1B | $2.2B | ||
| Q3 24 | $8.1B | $2.1B | ||
| Q2 24 | $9.0B | $2.0B | ||
| Q1 24 | $10.8B | $2.2B |
负债/权益比DAYMD
| Q4 25 | — | 0.66× | ||
| Q3 25 | 0.23× | 0.65× | ||
| Q2 25 | 0.23× | 0.70× | ||
| Q1 25 | 0.24× | 0.75× | ||
| Q4 24 | 0.47× | 0.78× | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.49× | — | ||
| Q1 24 | 0.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $31.2M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DAYMD
| Q4 25 | — | $114.1M | ||
| Q3 25 | $31.2M | $137.3M | ||
| Q2 25 | $112.7M | $137.2M | ||
| Q1 25 | $49.6M | $-117.5M | ||
| Q4 24 | $81.0M | $133.0M | ||
| Q3 24 | $91.8M | $91.8M | ||
| Q2 24 | $99.2M | $107.0M | ||
| Q1 24 | $9.1M | $-125.2M |
现金转化率DAYMD
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | 5.29× | 3.49× | ||
| Q1 25 | 3.33× | -5.66× | ||
| Q4 24 | 7.50× | 4.36× | ||
| Q3 24 | 45.90× | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.28× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAY
| Dayforce Recurring | $333.0M | 69% |
| Cloud And Bureau Professional Services And Other | $78.5M | 16% |
| Float | $42.2M | 9% |
| Powerpay Recurring | $19.7M | 4% |
| Other Recurring | $8.2M | 2% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
